---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-126074"
form_type: "8-K"
ticker: "BDTX"
cik: "0001701541"
company_name: "Black Diamond Therapeutics, Inc."
filed_at: "2022-12-12T23:59:59+00:00"
generated_at: "2026-06-21T06:13:11.596875+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Black Diamond Therapeutics spins out Launchpad Therapeutics with $30M Series A from Versant and NEA

## Summary
- Spinout of Launchpad, an antibody-focused precision oncology company; $30M Series A led by Versant Ventures and NEA.
- Black Diamond contributed undisclosed early-stage antibody programs and licensed its MAP Drug Discovery Engine to Launchpad.
- Black Diamond received 9.0 million shares of Launchpad common stock (minority stake) for the contributed assets and license.
- Black Diamond will continue focus on BDTX-1535, BDTX-4933, and small molecule pipeline while retaining upside via equity stake.
- Launchpad will use the MAP Engine for large molecule discovery and development of novel antibody therapeutics.

## SEC filing metadata
- accession: 0001104659-22-126074
- form_type: 8-K
- ticker: BDTX
- cik: 0001701541
- company_name: Black Diamond Therapeutics, Inc.
- filed_at: 2022-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1701541/000110465922126074/0001104659-22-126074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1701541/000110465922126074/tm2232368d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-126074
- JSON: https://secwatch.observer/filing/0001104659-22-126074.json
- Plain text: https://secwatch.observer/filing/0001104659-22-126074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.